Ephedra fragilis
Ephedra fragilis · Accepted scientific name
Scientific literature: Very Sparse (0 studies) · ★☆☆☆☆
Ephedra fragilis is a distinctive plant species known for its unique chemical profile and traditional medicinal applications. It contains a diverse array of bioactive compounds, including catechins, flavonoids, and hydroxycinnamic acids. Notably, the presence of rutin within its composition contributes to its complex phytochemical makeup. For therapeutic purposes, the plant is commonly utilized through specific preparations such as decoction or infusion. Understanding these chemical properties and preparation methods is essential for exploring the plant's botanical significance.
- Synonyms
- Not available
- Common names
- Not available
- Family
- Ephedraceae
- Distribution
- Asia-Tropical
- Plant Parts
- Not available
Classification
Common Names
Ephedra fragilis is a botanical species known by a variety of distinct regional and linguistic names. In many English-speaking areas, it is commonly referred to as Joint Pine, though it is also identified as Sorjaefedra. Depending on the cultural context, the plant may be called Trompera fràgil to reflect specific local traditions. In Czech-speaking regions, the species is recognized through the names chvojník krehký or chvojník křehký. These diverse monikers illustrate the widespread recognition of this plant across different parts of the world.
Sources: Catalogue of Life (COL)
Taxonomy
Ephedra fragilis is a unique botanical specimen that belongs to the kingdom Plantae. Within this vast kingdom, the species is classified under the class Equisetopsida. It further descends through the order Ephedrales and the specific family Ephedraceae. This plant is a distinguished member of the genus Ephedra, showcasing specialized evolutionary traits. Through these taxonomic relationships, its precise place in the natural world is clearly defined.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Gnetidae |
| Order | Ephedrales |
| Family | Ephedraceae |
| Genus | Ephedra |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Ephedra fragilis exhibits a broad geographical distribution that spans across several key regions. This plant is widely found throughout Africa, including specific territories within Macaronesia such as the Canary Islands and Madeira. Its presence is particularly notable across Northern Africa, where it thrives in diverse environments. More specifically, documented populations can be located within the borders of Algeria, Libya, and Morocco. This widespread range highlights the plant's ability to adapt to various Mediterranean and subtropical climates.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Ephedra fragilis typically presents as a shrubby plant, though it can also exhibit a facultative climbing habit depending on its environment. This versatile species generally reaches a maximum height of 2 meters. Its unique growth patterns allow it to adapt effectively to diverse structural supports in its habitat.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Compounds
Ephedra fragilis is a medicinal plant recognized for its diverse array of bioactive compounds and significant therapeutic potential. Through high-performance liquid chromatography analysis, researchers have identified several major phytochemical constituents within the plant. Specifically, the studies confirm that Ephedra fragilis contains catechin, which contributes to its complex chemical profile. Additionally, the presence of rutin and caffeic acid further enhances the plant's richness in polyphenols and hydroxycinnamic acids. These findings underscore the importance of selecting efficient extraction methods to fully recover these valuable antioxidant components.
Conditions
Preparations
Ephedra fragilis is prepared as both a decoction and an infusion to study its phytochemical profile. These two aqueous extraction methods are used to evaluate the plant's antioxidant activity and bioactive content. Research indicates that the plant is processed as a decoction to maximize the recovery of secondary metabolites. It is also prepared as an infusion, though this method yields a lower antioxidant capacity than the decoction. Ultimately, the choice between preparing Ephedra fragilis as a decoction or an infusion significantly impacts the concentration of its medicinal compounds.